_immunotherapy-added-to-chemotherapy-improves-pathological-complete-response-in-early-triple-negative-breast-cancer.jpg "Immunotherapy added to chemotherapy improves pathological complete response in early triple negative breast cancer from immunotherapy in cancer Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 4 min 12 sec
✓ Published: 29-Sep-2019
✓ Published: 29-Sep-2019
Description:
Prof Peter Schmid presents data from theKEYNOTE-522 trial during a press conference at the 2019 ESMO congress.nnThis was a phase III trial looking at immunotherapy added to chemotherapy in early triple negative breast cancer.nnSign up to ecancer for free to receive tailored email alerts for more videos like this.necancer.org/account/register.php
Prof Peter Schmid presents data from theKEYNOTE-522 trial during a press conference at the 2019 ESMO congress.nnThis was a phase III trial looking at immunotherapy added to chemotherapy in early triple negative breast cancer.nnSign up to ecancer for free to receive tailored email alerts for more videos like this.necancer.org/account/register.php
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_change-the-world-campaign-video124-dana-farber-cancer-institute-boston-ma.webp "The research done by Dana-Farber Cancer Institute has influenced cancer treatment everywhere. Most pivotal was discovering PD-L1, a protein cancer uses to hide from the immune system. Blocking the PD-L1 pathway enables the immune system to attack cancer. Finding PD-L1 has transformed immunotherapy into a major approach for treating cancer worldwide. From pioneering chemotherapy to harnessing the immune system, Dana-Farber has led the way in cancer breakthroughs for 72 years.What we do here, ch")
⏲ 1 min 20 sec ✓ 27-Mar-2020
_immunotherapy-for-cancer-what-it-is-and-why-its-used.webp "Cancer Center")
_immunotherapy-the-path-to-a-cancer-cure-for-clinicians.webp "Society for Immunotherapy of Cancer")
_cancer-immunotherapy.webp "Nucleus Medical Media")
_advances-in-immunotherapy-for-cancer-treatment.webp "Cleveland Clinic")
_immunotherapy-treatment-of-cancer-holly-cardillo.webp "Holly Cardillo, a junior in bioengineering at Penn State, discusses a new cancer treatment. In this talk, Holly uses the assertion-evidence approach.")
_understanding-immunotherapy-for-lung-cancer.webp "You and Lung Cancer")
_change-the-world-campaign-video124-dana-farber-cancer-institute-boston-ma.jpg)
_immunotherapy-for-cancer-what-it-is-and-why-its-used.jpg)
_immunotherapy-the-path-to-a-cancer-cure-for-clinicians.jpg)
_cancer-immunotherapy.jpg)
_advances-in-immunotherapy-for-cancer-treatment.jpg)
_immunotherapy-treatment-of-cancer-holly-cardillo.jpg)
_understanding-immunotherapy-for-lung-cancer.jpg)
![[+]](/images/menu.gif){kind=small}